1. Home
  2. PRME vs FPI Comparison

PRME vs FPI Comparison

Compare PRME & FPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

N/A

Current Price

$3.16

Market Cap

553.2M

Sector

Health Care

ML Signal

N/A

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

N/A

Current Price

$10.98

Market Cap

464.7M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
PRME
FPI
Founded
2019
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
553.2M
464.7M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
PRME
FPI
Price
$3.16
$10.98
Analyst Decision
Buy
Hold
Analyst Count
6
1
Target Price
$7.56
N/A
AVG Volume (30 Days)
2.7M
543.3K
Earning Date
05-08-2026
04-29-2026
Dividend Yield
N/A
3.14%
EPS Growth
18.18
N/A
EPS
N/A
0.08
Revenue
$4,632,000.00
$52,178,000.00
Revenue This Year
$7.06
N/A
Revenue Next Year
$47.01
N/A
P/E Ratio
N/A
$135.56
Revenue Growth
55.28
N/A
52 Week Low
$2.67
$9.21
52 Week High
$6.94
$13.23

Technical Indicators

Market Signals
Indicator
PRME
FPI
Relative Strength Index (RSI) 40.43 69.16
Support Level $2.73 $10.77
Resistance Level $3.72 $10.93
Average True Range (ATR) 0.21 0.22
MACD -0.06 0.01
Stochastic Oscillator 11.63 89.37

Price Performance

Historical Comparison
PRME
FPI

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

Share on Social Networks: